Hikma Pharmaceuticals

Hikma Pharmaceuticals

World Rank (Aug-2026)
3813
Market Cap (Aug-2026)
4.631 Billion USD
World Rank (Jan-05-2024)
2,843
Market Cap (Jan-05-2024)
5.182 Billion USD
World Rank (Jul-30-2023)
2,549
Market Cap (Jul-30-2023)
5.954 Billion USD
World Rank (Jan-07-2022)
2,587
Market Cap (Jan-07-2022)
6.713 Billion USD
World Rank (Jan-01-2021)
2,018
Market Cap (Jan-01-2021)
7.937 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 87
Headquarters Country
UK
Top Healthcare Companies in UK
Top Healthcare Companies in Europe
Top Pharmaceutical Companies in Europe
Employee Count
8,800
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
3,349 Million USD
Annual Operating Income in USD
633 Million USD
Annual Net Income in USD
402 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
5,671 Million USD
Total Liabilities in USD
3,065 Million USD
Total Equity in USD
2,606 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
HIKMA PHARMACEUTICALS
Wikipedia
Wikipedia
Yahoo
Yahoo @ LSE
Company Profile

Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.

Facts About Company

HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.

HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.

As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.

Annual Results Summary

HIKMA PHARMACEUTICALS - Annual Results - Revenue and Net Income - in Million USD:

Year-EndingRevenueOperating IncomeNet Income
Dec-20232,875604190
Dec-20222,517482188
Dec-20212,553597421
Dec-20202,341560431
Dec-20192,207450486
Dec-20182,070378282
Balance Sheet Summary

Total Assets as on Dec-2023 was 4,680 Million USD.

Total Liabilities as on Dec-2023 was 2,471 Million USD.

Total Equity as on Dec-2023 was 2,209 Million USD.

Founded Year
1978
ISIN Code
GB00B0LCW083
Stock Exchange
Frankfurt
LSE

Share